CERS — Cerus Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall CapNeutral
- $408.05m
- $387.12m
- $188.32m
- 56
- 26
- 36
- 32
Annual cashflow statement for Cerus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -57.6 | -71.2 | -59.9 | -54.4 | -42.8 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 11.6 | 15.3 | 19.7 | 26.7 | 30.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.2 | -12.3 | -3.7 | -9.42 | -15.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -31.2 | -65.8 | -40.7 | -33.9 | -25.6 |
| Capital Expenditures | -1.14 | -8.94 | -1.61 | -0.91 | -2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -42.7 | 37.1 | -47.9 | 13.6 | 10.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -43.8 | 28.2 | -49.6 | 12.7 | 8.46 |
| Financing Cash Flow Items | — | — | — | 1 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 92.8 | 43.5 | 91.8 | 34.3 | 4.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.7 | 5.83 | 1.48 | 12.1 | -13.7 |